Elsevier

Hearing Research

Volume 236, Issues 1–2, February 2008, Pages 52-60
Hearing Research

Research paper
Cytotoxic effects of dimethyl sulphoxide (DMSO) on cochlear organotypic cultures

https://doi.org/10.1016/j.heares.2007.12.002Get rights and content

Abstract

The amphipathic molecule dimethyl sulphoxide (DMSO) is a solvent often used to dissolve compounds applied to the inner ear; however, little is known about its potential cytotoxic side effects. To address this question, we applied 0.1–6% DMSO for 24 h to cochlear organotypic cultures from postnatal day 3 rats and examined its cytotoxic effects. DMSO concentrations of 0.1% and 0.25% caused little or no damage. However, concentrations between 0.5% and 6% resulted in stereocilia damage, hair cell swelling and a dose-dependent loss of hair cells. Hair cell damage began in the basal turn of the cochlea and spread towards the apex with increasing concentration. Surprisingly, DMSO-induced damage was greater for inner hair cells than outer hair cell whereas nearby supporting cells were largely unaffected. Most hair cell death was associated with nuclear shrinkage and fragmentation, morphological features consistent with apoptosis. DMSO treatment induced TUNEL-positive staining in many hair cells and activated both initiator caspase-9 and caspase-8 and executioner caspase-3; this suggests that apoptosis is initiated by both intrinsic mitochondrial and extrinsic membrane cell death signaling pathways.

Introduction

Dimethyl sulphoxide (DMSO), an amphipathic solvent soluble in both water and organic substances, is often used to dissolve hydrophobic substances used in biological research. DMSO has a number of important properties that make it useful clinically. DMSO has been used successfully to treat urinary (McCammon et al., 1998), pulmonary (Iwasaki et al., 1994), rheumatic (Morassi et al., 1989) and dermatological disorders (Burgess et al., 1998). Because of its anti-inflammatory and anti-oxidant properties, DMSO has also been used with some success to treat gastrointestinal disorders (Salim, 1992a, Salim, 1992b). Since DMSO can act as a free-radical scavenger and can cross the blood–brain barrier, it has also been used to treat brain edema (Broadwell et al., 1982, Ikeda and Long, 1990). Although clinically beneficial in some situations, DMSO can have systemic side effects such as diarrhea, vomiting, bronchospasm, hypertension, and pulmonary edema (Davis et al., 1990, Hameroff et al., 1983, Smith et al., 1987, Stroncek et al., 1991). These effects appeared to be dose-dependent (Davis et al., 1990, Stroncek et al., 1991).

The effects of DMSO on cellular function have been studied in a large number of cell types, but with variable results. Some studies have shown that DMSO blocks the rise of intracellular calcium induced by different agents (Reynaud et al., 1999, Saldanha et al., 2002, Santos et al., 2002, Zhang and Eyzaguirre, 1999). Others have reported that DMSO causes an increase in extracellular sodium, potassium and calcium (Santos et al., 2002). DMSO has diverse effects on ion transporters and pumps (Santos et al., 2002). In mouse lymphoma cells, 18 h treatment with 2.5% DMSO induced an apoptotic response consisting of a decline in Bcl-2, a decrease in the mitochondrial membrane potential, the release of cytochrome c from mitochondria, activation of initiator caspase-9 and executioner caspase-3 (Liu et al., 2001). Studies with lymphoma cells suggest that DMSO concentrations of 1–2% prevent apoptosis whereas higher concentrations induces apoptosis (Lin et al., 1995). DMSO enhances the suppressive effects on lidocaine on synaptic transmission (Somei et al., 1995). DMSO (10%) is often used as a cryoprotectant to optimize cell survival in vitro and in vivo (Davis et al., 1990, Trumble and Whalen, 1992). However, when used in vivo DMSO did not protect peripheral nerves from cryoinjury and exacerbated functional recovery (Trumble and Whalen, 1992).

Several studies have used DMSO to dissolve otoprotective compounds that are given systemically or applied locally to the middle ear or round window membrane of the cochlea. NMDA receptor antagonists, in the form of maleate and tartrate salts (metal chelators) dissolved in DMSO and administered systemically protected against aminoglycoside ototoxicity (Basile et al., 1996). However, when sodium maleate or tartaric acid dissolved in DMSO (40%) were given without the NMDA receptor antagonists, they also provided significant protection against aminoglycoside damage (Sha and Schacht, 1998). These findings suggested that the metal-chelating and anti-oxidant properties of these agents acting alone or in combination were protecting against aminoglycoside ototoxicity. Another study infused Texas Red and DMSO into the middle ear space as a control in order to study the distribution of the tracer within the inner ear (Liu et al., 2006). The abstract did not mention the concentration and volume of DMSO applied to the round window or if DMSO caused any cochlear damage. Src protein tyrosine kinase inhibitors dissolved in DMSO (<0.5%) have been placed on to the round window to determine if they would protect against noise induced hearing loss (Harris et al., 2005). No negative side effects from the solvent were reported.

Others have dissolved compounds in DMSO in order to facilitate the entry of these compounds into isolated hair cells (Canlon and Dulon, 1993, Szonyi et al., 1999, Szonyi et al., 2001). One percent DMSO applied to acutely isolated outer hair cells (OHC) resulted in a significant decrease in OHC electromotility (Canlon and Dulon, 1993); the reduction in electromotility was reversed by increasing the concentration of ionomycin, a calcium ionophore (Szonyi et al., 2001). These results indicate that low concentrations of DMSO can exert an immediate effect on OHC function.

Although DMSO is often used to dissolve compounds that are applied to the inner ear in vivo and in vitro, the physiologic and anatomical effects of DMSO on the cochlea are poorly understood. Since DMSO could conceivably cause negative side effects, we applied different concentration of DMSO to cochlear organotypic cultures to evaluate its cytotoxic effects on cochlear organotypic cultures. In contrast to in vitro studies, the cochlear culture preparation offers precise control of the amount of DMSO that can be applied to the inner ear.

Section snippets

Cochlear organotypic cultures

Our procedures for preparing cochlear organotypic cultures have been described in detail in earlier publications (Corbacella et al., 2004, Ding et al., 2002, Ding et al., 2007, Lanzoni et al., 2005). Rat pups (CDF (F344), Charles River Laboratory Inc.) were decapitated on postnatal days 2–3. The cochlea was carefully removed, the lateral wall dissected away and the whole basilar membrane containing the organ of Corti and spiral ganglion neurons removed as a flat surface preparation. A drop (15 

Hair cells damage

Fig. 1A shows a normal control cochlea maintained in culture for 24 h and then stained with Alexa 488-phalloidin to label the actin that is heavily expressed in the stereocilia and cuticular plate of hair cells. Three orderly rows of OHC and one row of IHC were present in normal control cochlear cultures (Fig. 1A). Cochlear cultures treated with 0.1% DMSO were indistinguishable from normal control cultures (data not shown). However, when the concentration of DMSO was increased to 0.5%, mild

Discussion

DMSO is an amphipathic molecule with a polar domain and two apolar methyl groups making it soluble in both aqueous and organic media. It is one of the most common solvents for dissolving hydrophobic compounds employed in vivo or in vitro studies. DMSO has frequently been used in studies of the inner ear; however, its potential side effects are unknown and have been largely overlooked in previous studies (Basile et al., 1996, Guitton et al., 2003, Harris et al., 2005, Lee and Marcus, 2002, So et

Acknowledgement

Research supported by NIH grant R01 DC00630.

References (46)

  • C.K. Lin et al.

    Dimethyl sulfoxide suppresses apoptosis in Burkitt’s lymphoma cells

    Exp. Cell Res.

    (1995)
  • J. Liu et al.

    Involvement of mitochondrial permeability transition and caspase-9 activation in dimethyl sulfoxide-induced apoptosis of EL-4 lymphoma cells

    Int. Immunopharmacol.

    (2001)
  • K.A. McCammon et al.

    Intravesical dimethyl sulfoxide for primary amyloidosis of the bladder

    Urology

    (1998)
  • D. Reynaud et al.

    Hepoxilin signaling in intact human neutrophils: biphasic elevation of intracellular calcium by unesterified hepoxilin A3

    FEBS Lett.

    (1999)
  • N.C. Santos et al.

    Biochemical, biophysical and haemorheological effects of dimethylsulphoxide on human erythrocyte calcium loading

    Cell Calc.

    (2002)
  • H.S. So et al.

    Protective effect of T-type calcium channel blocker flunarizine on cisplatin-induced death of auditory cells

    Hear. Res.

    (2005)
  • M. Szonyi et al.

    Cyclic GMP and outer hair cell electromotility

    Hear. Res.

    (1999)
  • M. Szonyi et al.

    Intracellular calcium and outer hair cell electromotility

    Brain Res.

    (2001)
  • M. Zhang et al.

    Pifithrin-alpha suppresses p53 and protects cochlear and vestibular hair cells from cisplatin-induced apoptosis

    Neuroscience

    (2003)
  • X.Q. Zhang et al.

    Effects of hypoxia induced by Na2S2O4 on intracellular calcium and resting potential of mouse glomus cells

    Brain Res.

    (1999)
  • A.S. Basile et al.

    N-methyl-d-aspartate antagonists limit aminoglycoside antibiotic-induced hearing loss

    Nat. Med.

    (1996)
  • R.D. Broadwell et al.

    Morphologic effect of dimethyl sulfoxide on the blood–brain barrier

    Science

    (1982)
  • J.L. Burgess et al.

    Sulfhemoglobinemia after dermal application of DMSO

    Vet. Hum. Toxicol.

    (1998)
  • Cited by (160)

    • Application of modified aldehyde compounds in self-etching bonding of dentin

      2023, Journal of the Mechanical Behavior of Biomedical Materials
    View all citing articles on Scopus
    View full text